← Back to news
S

Seeking Alpha: News

Soleno Therapeutics reports prelim Q4 rev above estimate

S

These mid-cap financials lag as EPS revisions signal softer momentum ahead of earnings

S

Mid-cap financial stocks that shine with top EPS revisions

S

Bill Pulte denies role in Fed subpoenas in a recent Bloomberg interview

S

Axalta downgraded at UBS as Akzo deal tempers near-term upside

S

Albemarle, Lithium Argentina hit new 52-week highs as Scotiabank upgrades

S

Blackstone moves to exit U.K. rental home platform Leaf Living - report

B

Hertz Global slips after the Supreme Court declines to hear bond payout case

B

UK to bring into force law against companies providing tools for AI deepfakes: report

B

Sarepta guides Q4 sales below estimates

B

Atara plummets on FDA Complete Response Letter for tabelecleucel

B

Sen. Murkowski joins Tillis on backing Fed independence

B

Trump Administration nears trade deal with Taiwan; TSM ticks up: report

S

Day One projects 2026 OJEMDA U.S. net product revenue between $225M - $250M

S

Worst small-cap financial stocks by EPS revisions as earnings season nears

S

Liberty All-Star Growth declares $0.12 dividend

S

Liberty All-Star Equity declares $0.18 dividend

S

Grail rises as 2025 revenue guidance above consensus

S

Best and worst-rated financial stocks heading into earnings

S

Airbus beats revised delivery goal with 793 aircraft in 2025

S

GE Vernova gets new Street-high price target at GLJ but Baird cuts on oversupply worries

S

CFPB, DOJ withdraw Biden-era guidance on non-citizen borrowers

S

Credit card interest cap will hurt banks, economy, consumers, Wall Street analysts say

S

NVIDIA deepens life sciences push with BioNeMo expansion, new lab partnerships

S

Zumiez lowers Q4 sales outlook on soft international and footwear results

S

SA analyst upgrades/downgrades: ORCL, M, COIN, NVO

S

Noodles & Company posts higher Q4 comparable sales in preliminary update

S

Brookdale reports December 2025 occupancy

S

Market Voices: Powell, Tillis, former Fed chairs on DOJ probe

S

Google reaches $4T market cap as Gemini shines bright

S

Dover added as a new long idea at Hedgeye

S

Regenxbio rises on data for Duchenne muscular dystrophy candidate

S

Pacific Biosciences to collaborate with foundations on rare genetic disease therapies

S

BHP not planning rival bid as Rio Tinto pursues Glencore mega-merger - Reuters

S

BARK rallies 31% after attracting a go-private offer

S

Ultragenyx sees FY25 revenue between $672M and $674M

S

Axogen sees Q4 net sales of up to $59.9M and FY2025 at $225.2M

S

Dynavax gains on disclosure another bidder interested after deal announced

S

PTC Therapeutics projects FY26 product revenue between $700M to $800M

S

Boot Barn issues positive guidance update on strong western boots, denim demand

S

CACI International secures $416 million contract from U.S. Navy

S

Akebia therapeutics announces corporate updates and 2026 pipeline outlook

S

HUB Cyber Security appoints Limor Zur-Stoller as CFO

S

AmpliTech receives $9M from $4 unit subscription rights offering

S

UBS opposes Swiss proposal to tighten banking rules after Credit Suisse collapse - report

S

Lulu’s Fashion Lounge surges 45% after Friedland Enterprises takes 5% stake, pushes governance reforms

S

Petco seeks to refinance $1.5B debt, reaffirms guidance

S

The best large cap energy stocks by EPS revisions

S

Datadog, Appian both receive upgrades to Overweight by Morgan Stanley

S

HealthEquity expects FY 2027 revenue between $1.38B and $1.41B; shares down over 7%

S